Skip to content

NovoCure NVCR Interest coverage

Interest coverage at other companies

Boston Scientific logo
Boston ScientificBSX
10.6×+1.7×
Medtronic logo
MedtronicMDT
9.1×+0.9×
Nuvation Bio logo
Nuvation BioNUVB
-7.4×-3.7×
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-55,882.3×
ALN
Alnylam PharmaceuticalsALNY
3.4×+2.9×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-7.1×-0.8×

Other financials

Income statement

See full
Revenue$174.1M+12.3%
Gross profit$135.1M+16.0%
Operating income-$67.4M-78.1%
Net income-$71.1M-107%
EPS (diluted)-$0.62-100%

Balance sheet

See full
Cash & equivalents$87.5M-31.2%
Total debt$39.5M-2.1%
Total equity$330.7M-8.6%
Total assets$787.9M-36.9%

Cash flow

See full
Operating cash flow-$13.5M+62.1%
CapEx$5.2M-51.4%
Free cash flow-$18.7M+59.7%

Valuation

See full
Market cap$1.7B-36.7%

Profitability

See full
Gross margin75.2%-2.0pp
Operating margin-27.2%+0.4pp
Net margin-25.7%-0.7pp
FCF margin-7.1%-2.0pp

Returns & leverage

See full
Return on equity-50%+5.4pp
Debt / equity0.1×0.0×
Current ratio2.9×+1.4×

Where this comes from

Calculated from NovoCure’s reported figures.

Based on trailing twelve months.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NovoCure's interest coverage?
NovoCure (NVCR) reported interest coverage of -21.1× in Q1 2026.
How has NovoCure's interest coverage changed year-over-year?
NovoCure's interest coverage decreased by 367.6% year-over-year, from -4.5× to -21.1×.
What is the long-term trend for NovoCure's interest coverage?
Over 3 years (2022 to 2025), NovoCure's interest coverage has grown at a 13.8% compound annual growth rate (CAGR), from -5.8× to -8.5×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.